Xvivo Perfusion AB
XVIVO.ST
#5119
Rank
A$1.95 B
Marketcap
$62.05
Share price
-0.22%
Change (1 day)
66.79%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): A$17.4 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are A$65.99 Million. In 2023 the company made an earning of A$14.4 Million, an increase over its 2022 earnings that were of A$3.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$17.4 M20.85%
2023 A$14.4 M309.49%
2022 A$3.51 M226.49%
2021 A$1.07 M-110.72%
2020 -A$10.06 Million-1221.07%
2019 A$0.89 M-70.61%
2018 A$3.05 M117.32%
2017 A$1.4 M146.09%
2016 A$0.57 M-61.52%
2015 A$1.48 M-3.88%
2014 A$1.54 M-39.59%
2013 A$2.55 M